Entourage Effect Capital Looks for Opportunities to Build Scale in Its Portfolio in Advance of Cannabis Legalization

Exclusive Interview with Entourage Effect Capital Managing Partner Matt Hawkins

Over the course of the pandemic, Entourage Effect Capital has been looking inward to determine which of its portfolio companies needed support. The firm has kept reserve capital for follow-on investments. In 2020, it focused on those follow-on investments and offshoots of existing investments. Managing Partner Matt Hawkins spoke with New Cannabis Ventures about Entourage Effect Capital’s close relationship with Harborside and the future of the cannabis investment landscape. The audio of the entire conversation is available at the end of this written summary.


Taking over the Harborside board through a dissenting shareholder movement was one of Entourage Effect Capital’s biggest moves in 2020, according to Hawkins. He is now the Chairman of the company. Entourage Effect Capital has three goals for Harborside: hire a world-class CEO, pursue accretive M&A opportunities and settle with the IRS on 280E issues.

Entourage Effect Capital Works Closely with Its Portfolio Companies, As It Does with Harborside.

The firm’s work with Harborside offers a window into its approach. Entourage Effect Capital gets involved with its companies and works to bring people together. The firm invested a large amount in Harborside to further reduce its cost basis in that position. That deal is expected to be closed later this week, according to Hawkins.

The Entourage Effect Capital Portfolio

Entourage Effect Capital was an early investor in companies like Acreage, GTI and Ebbu. The firm has sold most of those positions at this point, with its first fund returning close to two times capital after the next distribution, according to Hawkins.

During his last conversation with New Cannabis Ventures, Hawkins spoke about Entourage Effect Capital’s third fund. The firm has yet to have a final closing on that instrument, according to Hawkins. He expects a number of investments to close in the first part of the year.

Top Markets

The firm is looking to build scale in as many segments of the cannabis supply chain as possible. Right now, Entourage Effect Capital is a significant investor in the California market. It is invested in companies like Harborside, Holistic Industries, Sunderstorm, Urbn Leaf and NorCal Cannabis Company.

Entourage Effect Capital Is Invested in MSOs, Like Holistic.

Entourage Effect Capital will continue to invest in California and branch out to explore opportunities in other markets in the Midwest and the Northeast. With New Jersey coming online, markets like Connecticut and New York are likely to follow. Large Midwestern markets, as well as state like Florida and Arizona, offer significant opportunities.

The Pandemic

With cannabis businesses largely deemed essential during the pandemic, 2020 was a strong year in terms of sales and profitability for the industry, according to Hawkins. While a challenge, the pandemic has served to curb some of the power of the illicit market. More customers have been attracted to the legal market, taking advantage of services like curbside pickup and delivery. Hawkins expects a change in how the industry is taxed will help to further tamp down the illicit market.

Legalization on the Horizon

The recent Democratic sweep has the potential to improve the return profile in the cannabis industry. The likely accelerated timeline to legalization will draw more institutional investors to the space, along with tobacco, alcohol, nutraceutical, big pharma and CPG players.

Entourage Effect Capital’s mission right now is to build scale in advance of legalization, at which point valuations are likely to skyrocket. With the right opportunities and the right teams, the firm wants to combine companies to achieve that scale.

Hawkins expects that the SAFE Banking Act will need to pass before institutional capital enters the industry en masse, but the firm is currently talking to some family offices that act like institutions. Entourage Effect Capital will be working with its portfolio companies to capitalize on the momentum of 2020, positioning to scale ahead of legalization and take advantage of that opportunity when it arrives.

To learn more, visit the Entourage Effect Capital website. Listen to the entire interview:

Exclusive article by Carrie Pallardy
Carrie Pallardy, a Chicago-based writer and editor, began her career covering the healthcare industry and now writes, edits and interviews subject matter experts across multiple industries. As a published writer, Carrie continues to tell compelling, undiscovered stories to her network of readers. For more information contact us.

Get Our Sunday Newsletter